about
Visualizing functional motions of membrane transporters with molecular dynamics simulationsNonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesSimple screening method for improving membrane protein thermostabilityMolecular modeling and ligand docking for solute carrier (SLC) transportersStudies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transportersIdentification of the substrate recognition and transport pathway in a eukaryotic member of the nucleobase-ascorbate transporter (NAT) familyHigh selectivity of the γ-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach.SLC6 transporters: structure, function, regulation, disease association and therapeuticsMolecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.Novel C-1 substituted cocaine analogs unlike cocaine or benztropine.The cost of living in the membrane: a case study of hydrophobic mismatch for the multi-segment protein LeuT.Coupled global and local changes direct substrate translocation by neurotransmitter-sodium symporter ortholog LeuT.DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action.Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters.Inhibitory action of antidepressants on mouse Betaine/GABA transporter (BGT1) heterologously expressed in cell cultures.Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases.
P2860
Q26826746-CC9D51F0-6669-4337-8F6D-A5067E7AAF92Q26853319-5E81546F-BEEF-4D5E-9345-4ACC3E173216Q28245517-9B396A04-3BF8-4011-A8E6-795E6E3B1572Q33751096-8E800C85-FF8C-49AF-A8D7-B5B19E0FC28AQ34249270-1ECC60DB-D9F8-4F9C-8F69-183A53C37523Q34359270-98D4071D-5775-476F-995E-9186D3CF98FBQ34397703-A79C9C74-95F2-4F0C-89AA-7466C65BCFE5Q34649517-02BDEEEC-6729-4FC9-95FA-C30E940C0309Q35123142-75AAA152-74CD-423A-9315-E70A4BDC27F6Q35229337-B0890725-B247-4905-8148-7C71ED30E50DQ36335545-3D0D630C-83F6-42CF-81B9-257C2633055DQ36781347-8A337CB1-CC69-45A3-A1FE-A3E51795D372Q37078300-A8BDC124-CF61-4C0C-9101-F7D0B83997B0Q38223203-A7B63E84-917E-45A6-A196-C95327A63919Q38259553-9964CDC2-1FED-430A-973E-218FA6A88EB3Q42143662-20D16CE4-03BC-467D-B7C8-CD604C162AAAQ47720903-483A0F73-FF85-4EEF-8BD1-0BCD1391CD6D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Substrate and drug binding sites in LeuT.
@en
Substrate and drug binding sites in LeuT.
@nl
type
label
Substrate and drug binding sites in LeuT.
@en
Substrate and drug binding sites in LeuT.
@nl
prefLabel
Substrate and drug binding sites in LeuT.
@en
Substrate and drug binding sites in LeuT.
@nl
P2093
P2860
P1476
Substrate and drug binding sites in LeuT
@en
P2093
Ajeeta Nyola
Jennifer Marden
Maarten E Reith
Nathan K Karpowich
P2860
P304
P356
10.1016/J.SBI.2010.05.007
P577
2010-06-16T00:00:00Z